GANSU LONGSHENRONGFA PHARMACEUTICAL INDUSTRY CO.,LTD

Altre lingue Gansu Longshenrongfa Pharmaceutical Industry CO.,LTD

Azioni

300534

CNE100002CP5

Prezzo di chiusura Shenzhen S.E. Altri mercati azionari 00:00:00 30/04/2024			Variaz. 5gg	Var. 1 gen.
8,23 ^CNY	+0,98%		+3,26%	-16,62%

26/04	Gansu Longshenrongfa Pharmaceutical Industry CO.,LTD riporta i risultati degli utili per il primo trimestre conclusosi il 31 marzo 2024	CI
24/04	Gansu Longshenrongfa Pharmaceutical Industry CO.,LTD propone il dividendo finale in contanti per il 2023	CI

Altre lingue

Sblocca tutte le notizie su tutte le aziende: non perdere mai più un'opportunità di investimento redditizia!

Registrazione 100% gratuita

Gansu Longshenrongfa Pharmaceutical Industry CO.,LTD Reports Earnings Results for the First Quarter Ended March 31, 2024	26/04
Gansu Longshenrongfa Pharmaceutical Industry CO.,LTD Proposes Final Cash Dividend for 2023	24/04
Gansu Longshenrongfa Pharmaceutical Industry CO.,LTD Reports Earnings Results for the Full Year Ended December 31, 2023	23/04
Gansu Longshenrongfa Pharmaceutical Industry CO.,LTD cancelled the transaction announced on July 17, 2023	21/03
Gansu Longshenrongfa Pharmaceutical Industry CO.,LTD Reports Earnings Results for the Nine Months Ended September 30, 2023	17/10/23
Longshenrongfa Pharmaceutical Renews Food Production License	14/09/23
Gansu Longshenrongfa Pharmaceutical Industry CO.,LTD Reports Earnings Results for the Half Year Ended June 30, 2023	25/08/23
Gansu Longshenrongfa Pharmaceutical Industry CO.,LTD announced that it expects to receive CNY 485.796067 million in funding from Gansu Pharmaceutical Investment Group Co., Ltd., Gansu Great Wall Xinglong Silk Road Fund Management Co., Ltd. and other investors.	17/07/23
An unknown buyer agreed to acquire 7.1% stake in Gansu Longshenrongfa Pharmaceutical Industry CO.,LTD for CNY 234.5 million.	05/06/23
Gansu Longshenrongfa Pharmaceutical Industry CO.,LTD Reports Earnings Results for the First Quarter Ended March 31, 2023	24/04/23
Gansu Longshenrongfa Pharmaceutical Industry CO.,LTD Reports Earnings Results for the Full Year Ended December 31, 2022	14/04/23
Chinese Shares Rebound; Longshenrongfa Pharma Rises 3.9% on Renewal of Drug Production License	15/03/23
Gansu Longshenrongfa Pharma Renews Drug Production License	15/03/23
Drug Regulator Approves Changes to Longshenrongfa Pharma's Drug Production License	16/02/23
Longshenrongfa Pharma Gets Nod for Proposed Changes in License	10/02/23
Gansu Longshenrongfa Pharmaceutical Industry Co.,Ltd completed the acquisition of 70% stake in Gansu Pu'an Pharmaceutical Co.,Ltd. from Gansu Province Farms Agribusiness Ref co Group Ltd.	07/02/23
Longshenrongfa Pharma Gets Provincial Regulator's Nod for Cough Capsules	06/01/23
Gansu Longshenrongfa Leases Properties to Affiliates	14/11/22
Gansu Longshenrongfa Pharmaceutical Industry CO.,LTD Reports Earnings Results for the Nine Months Ended September 30, 2022	26/10/22
Gansu Longshenrongfa Pharmaceutical Industry CO.,LTD Reports Earnings Results for the Half Year Ended June 30, 2022	25/08/22

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue Gansu Longshenrongfa Pharmaceutical Industry CO.,LTD

Azioni

300534

CNE100002CP5

Altre lingue

Filtri